Departmental Associate, Sid Martin Biotechnology Incubator, University of Florida; CEO, Prometheon Pharma, LLC
Internal Medicine
Dr. Stephen I. Hsu, MD
|
|
Give Review
Stephen is an expert in the field of Internal Medicine. He studied medicine at Albert Einstein College of Medicine of Yeshiva University. He over the years received 19 awards: "Finalist (Final Four)", "Inaugural Award for Innovations in Research Training and Education", "Semi-Finalist (Sweet Sixteen)", "Excellence in Teaching Award", "Donald Etzweiler Visiting Scholar", "Clinical Translational Science Institute Scholar Award", "Clinician-Scientist Award", "Gottschalk Award", "Best Clinical Science Poster Award Finalist", "Doctor Award Finalist", "Merit Award", "Blue Ribbon Poster Award", "Young Investigator Award", "Royal Society of Medicine Library Prize", "The Pharos Editors Prize", "Best Basic Science Poster Award", "Alpha Omega Alpha Medical Honor Society", "Upjohn Achievement Award" and "Award for distinguished performance in research (1st Prize)". Dr. Stephen I. Hsu is a published doctor as well. He has 23 publications published. The latest was: Topical lipophilic epigallocatechin-3-gallate on herpes labialis: a phase II clinical trial of AverTeaX formula.
Publications
- Topical lipophilic epigallocatechin-3-gallate on herpes labialis: a phase II clinical trial of AverTeaX formula.
- Compounds derived from epigallocatechin-3-gallate (EGCG) as a novel approach to the prevention of viral infections.
- Should MD-PhD programs encourage graduate training in disciplines beyond conventional biomedical or clinical sciences?
- Practicality of Intermittent Fasting in Humans and its Effect on Oxidative Stress and Genes Related to Aging and Metabolism.
- Blue light activates phase 2 response proteins and slows growth of a431 epidermoid carcinoma xenografts.
- A phase II clinical trial of a natural formulation containing tea catechins for xerostomia.
- Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative Metabolism, prevents diet-induced obesity and insulin resistance.
- Association of KLK3 (PSA) genetic variants With prostate cancer risk and PSA levels.
- Pathogenic role of NF-kappaB activation in tubulointerstitial inflammatory lesions in human lupus nephritis.
- CRM1-mediated nuclear export is required for 26 S proteasome-dependent degradation of the TRIP-Br2 proto-oncoprotein.
- Racial and genetic factors in IgA nephropathy.
- Exploiting the TRIP-Br family of cell cycle regulatory proteins as chemotherapeutic drug targets in human cancer.
- Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients With lupus nephr...
- The TRIP-Br family of transcriptional regulators is essential for the execution of cyclin E-mediated cell cycle progression.
- TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability.
- Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy.
- Coupled induction of iNOS and p53 upregulation in renal resident cells may be linked With apoptotic activity in the pathogenesis of progressive IgA nephropathy.
- The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1.
- Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors?
- Paradigms of public-private partnerships in end-stage renal disease care: the National Kidney Foundation Singapore.
- Taking a public health approach to the prevention of end-stage Renal disease: the NKF Singapore Program.
- Risk factors for proteinuria in a large, multiracial, southeast Asian population.
Schools
Albert Einstein College of Medicine of Yeshiva University
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Chronic Kidney Diseases
- Diabetes With Renal Manifestations
- View All
Doctors Specialties
- Nephrology
- Internal Medicine
Accepted Insurances
- Choice Plus POS II
- AvMed
- Cigna
- GEHA
- Choice Care PPO
- Select HMO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- United Healthcare
Awards
- Finalist (“Final Fourâ€Â)
- Inaugural Award for Innovations in Research Training and Education
- Semi-Finalist (“Sweet Sixteenâ€Â)
- Excellence in Teaching Award
- Donald Etzweiler Visiting Scholar
- Clinical Translational Science Institute Scholar Award
- Clinician-Scientist Award
- Gottschalk Award
- Best Clinical Science Poster Award Finalist
- Doctor Award Finalist
- Merit Award
- Blue Ribbon Poster Award
- Young Investigator Award
- Royal Society of Medicine Library Prize
- The Pharos Editor’s Prize
- Best Basic Science Poster Award
- Alpha Omega Alpha Medical Honor Society
- Upjohn Achievement Award
- Award for distinguished performance in research (1st Prize)
Education
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Albert Einstein College of Medicine of Yeshiva University
Helpful Reviews
Similar Doctors
|
|
Dr. Knut Kverneland Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hassan Jadid, MD |
|
|
Dr. Jorge E. Fuentes, MD |
|
|
Dr. Ashkan Karimi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilicia L. Shugarman, MD |
|
|
Dr. Imtiaz M. Ather, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alfonso H. Santos Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. I D. Weiner, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anan B. Afaneh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Farrugia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet Caruso, MD
This Doctor is OpenDoctor Recommended.
|